
All things outdoors. Proud dad of boys. Biotech. CEO @Novomebio.
Joined March 2009
- Tweets27
- Following32
- Followers145
- Likes50
Blake Wise retweeted
#News: Excited to share we’ve secured $43.5 million in our Series B financing to advance our ongoing Phase 2a clinical trial in #hyperoxaluria and pipeline of #GEMMs candidates for #IBD. Learn more: novomebio.com #celltherapy #livingmedicines
Blake Wise retweeted
#News: Excited to share that we’ve appointed Bill McLeod as CFO to broaden our financing experience as we prepare for our next phase of growth. https://teapawt.net/t.co/fYN63I2prB #GEMMs #celltherapy #livingmedicines #CFO
Blake Wise retweeted
Dear Lawmakers @POTUS @RonWyden @SpeakerPelosi Hundreds of us biotech investors, innovators, patient advocates, & NIH academics representing >40k US jobs, >600 drugs in trials, & >$200B invested propose solutions to affordability that preserve R&D. 1/
nopatientleftbehind.docsend.…
Blake Wise retweeted
“We believe that our Genetically Engineered Microbial Medicine #celltherapies hold tremendous potential for patients across a wide range of diseases, including #UC and #IBS, in addition to #enterichyperoxaluria,” @blakewise @novomebio #MedTwitter https://teapawt.net/t.co/NLKAGbavPR
Blake Wise retweeted
How a Peninsula biotech hopes to give gut bacteria a boost to boot diseases in first-in-humans clinical trial
#kidneystones
@novomebio bizjournals.com/sanfrancisco… via @SFBusinessTimes
Blake Wise retweeted
#News: Excited to share we appointed Dr. Lachy McLean as Chief Medical Officer to lead our enteric #hyperoxaluria program into Phase 1/2a proof-of-concept. Learn more here: https://teapawt.net/t.co/1kJCKIqc7T #GEMMs #celltherapy #gutmicrobiome #livingmedicines
Blake Wise retweeted
Excited to share the news that Dave Cook (Forma Therapeutics) and Zach Hornby (Boundless Bio) have joined our Board. Looking forward to their contributions as we expand our GEMMs platform to engineer living medicines for chronic diseases! Learn more here: novomebio.com
Blake Wise retweeted
We're hiring! Looking for excellent Scientists and Research Associates to join our team, engineering gut bacteria as living medicines for chronic diseases.
Apply @ novomebiotechnologies.applyt…
#hiring #syntheticbiology #synbio #gutbacteria #microbiome #therapeutics
Blake Wise retweeted
Every so often, I re-read Dr. King’s Letter from a Birmingham Jail. While some of the injustices may have changed, his poetic brilliance, moral clarity, and tests of conscience still reverberate today. Take a moment to reflect on his righteous call: theatlantic.com/magazine/arc…
Blake Wise retweeted
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy
- by @frankvinluan / insight from CEO @blakewise
xconomy.com/san-francisco/20…
Blake Wise retweeted
With a $35M A round led by @DCVCBio, Novome is enineering microbes to produce a desired biologic after colonizing within the gut. @Novomebio buff.ly/3039rDr
Blake Wise retweeted
Critical legislation introduced in @CongressDotGov: Re-Valuing Anti-Microbial Products (REVAMP) Act of 2018 (Shimkus-Cardenas) creates #antibiotic pull incentives that would have a massive impact on companies' ability to address public health crisis https://teapawt.net/t.co/VisLh4Kecg
Blake Wise retweeted
This statement today from FDA Commissioner @SGottliebFDA is the most encouraging sign on a US government pull incentive in many a moon. He calls for paying for rarely-used novel antibiotics more like a software licenses. Worthy topic. fda.gov/NewsEvents/Newsroom/…
Blake Wise retweeted
Opinion: Without inventive approaches to funding the development of new antibiotics, we risk living — and dying — in a post-antibiotic era. buff.ly/2qkp2Nw
Blake Wise retweeted
Hey now, check out $AKAO! It's nice to see the good guys winning. Kudos to Kenneth Hillan and the team... finance.yahoo.com/quote/AKAO…
Blake Wise retweeted
re: @balajis, one thing some SV folks don't get: the main reason we don't have +miracle drugs is drug dev is *hard*, not because FDA is slow















